The antiviral effect of TRPV1 antagonist SB-705498 against GCRV infection via inflammation and apoptosis inhibition
Fish & Shellfish Immunology · 2026-09 · 176 · 111480
DOI: 10.1016/j.fsi.2026.111480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fish & Shellfish Immunology, 2026-09. Verfasst von Wei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Fisheries, Hunan Agricultural University, Changsha, 410128, China. Hauptthemen laut MEDLINE: TRPV Cation Channels, Apoptosis, Reoviridae Infections, Fish Diseases. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Grass carp reovirus (GCRV), the causative agent of grass carp hemorrhagic disease (GCHD), inflicts substantial economic losses in aquaculture, yet effective therapeutic interventions remain limited. Previous studies have demonstrated that the host factor CiTRPV1 facilitates GCRV infection by activating multiple pro-viral signaling pathways, underscoring its potential as an antiviral target. Here, we screened a library of TRPV1-targeting small molecules and identified three candidates with significant antiviral activity in Ctenopharyngodon idella kidney (CIK) cells. Based on its favorable selectivity index, previously reported safety data in mammalian studies, SB-705498 was selected for further evaluation. This reported TRPV1 antagonist potently suppressed GCRV replication in CIK cells, exhibiting a half-maximal inhibitory concentration (IC50) of 9.536 nM, and markedly alleviated virus-induced cytopathic effects (CPE). Mechanistic analyses suggested that SB-705498 mainly acts during the early stage of GCRV infection and suppresses capsaicin-induced TRPV1-associated Ca2+ signaling, while also attenuating virus-triggered inflammatory responses and apoptosis. In an infection model using rare minnows (Gobiocypris rarus), administration of SB-705498 significantly enhanced host survival and substantially reduced the relative abundance of GCRV VP4 RNA in key tissues, including the brain, gills, and skin. Together, these results identify SB-705498 as a promising anti-GCRV lead compound, providing a compelling rationale for developing host-directed antiviral therapeutics against GCHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Fisheries, Hunan Agricultural University, Changsha, 410128, China.
- College of Fisheries, Hunan Agricultural University, Changsha, 410128, China. Electronic address: lijunhua@hunau.edu.cn.
- College of Fisheries, Hunan Agricultural University, Changsha, 410128, China. Electronic address: liangxinyu@hunau.edu.cn.
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, W., Xie, Z., Xu, Y., Liu, J., Xia, H., Wu, C., Hu, L., Jiang, Y., Li, C., Li, J., & Liang, X. (2026). The antiviral effect of TRPV1 antagonist SB-705498 against GCRV infection via inflammation and apoptosis inhibition. Fish & Shellfish Immunology, 176, 111480. https://doi.org/10.1016/j.fsi.2026.111480
Vancouver
Wang W, Xie Z, Xu Y, Liu J, Xia H, Wu C, et al. The antiviral effect of TRPV1 antagonist SB-705498 against GCRV infection via inflammation and apoptosis inhibition. Fish & Shellfish Immunology. 2026;176:111480. doi:10.1016/j.fsi.2026.111480
BibTeX
@article{Wang2026,
author = {Wang, Wei and Xie, Ziyu and Xu, Yang and Liu, Jing and Xia, Haoyang and Wu, Chunya and Hu, Liang and Jiang, Yanxia and Li, Chun and Li, Junhua and Liang, Xinyu},
title = {The antiviral effect of TRPV1 antagonist SB-705498 against GCRV infection via inflammation and apoptosis inhibition},
journal = {Fish & Shellfish Immunology},
year = {2026},
volume = {176},
pages = {111480},
doi = {10.1016/j.fsi.2026.111480}
}
EUVIMED